EGF-Induced EMT and Invasiveness in Serous Borderline Ovarian Tumor Cells: A Possible Step in the Transition to Low-Grade Serous Carcinoma Cells?
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
In high-grade ovarian cancer cultures, it has been shown that epidermal growth factor (EGF) induces cell invasion by activating an epithelial-mesenchymal transition (EMT). However, the effect of EGF on serous borderline ovarian tumors (SBOT) and low-grade serous carcinomas (LGC) cell invasion remains unknown. Here, we show that EGF receptor (EGFR) was expressed, that EGF treatment increased cell migration and invasion in two cultured SBOT cell lines, SBOT3.1 and SV40 large T antigen-infected SBOT cells (SBOT4-LT), and in two cultured LGC cell lines, MPSC1 and SV40 LT/ST-immortalized LGC cells (ILGC). However, EGF induced down-regulation of E-cadherin and concurrent up-regulation of N-cadherin in SBOT cells but not in LGC cells. In SBOT cells, the expression of the transcriptional repressors of E-cadherin, Snail, Slug and ZEB1 were increased by EGF treatment. Treatment with EGF led to the activation of the downstream ERK1/2 and PI3K/Akt. The MEK1 inhibitor PD98059 diminished the EGF-induced cadherin switch and the up-regulation of Snail, Slug and ZEB1 and the EGF-mediated increase in SBOT cell migration and invasion. The PI3K inhibitor LY294002 had similar effects, but it could not block the EGF-induced up-regulation of N-cadherin and ZEB1. This study demonstrates that EGF induces SBOT cell migration and invasion by activating EMT, which involves the activation of the ERK1/2 and PI3K/Akt pathways and, subsequently, Snail, Slug and ZEB1 expression. Moreover, our results suggest that there are EMT-independent mechanisms that mediate the EGF-induced LGC cell migration and invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, the fallopian tube TME of primary HGSOC tumors is characterized by higher ECM deposition (especially laminin), dysplasia, loss of cellular polarity of fallopian tube epithelial cells, and release of several soluble factors that regulate ROS-induced stress, anoikis, invasion and cell growth (Cheng et al., 2012; Alsina-Sanchis et al., 2016; Huang et al., 2016; Micek et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Cheng et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816 · cited 1×
“Overexpression of HER2 has been shown in high-grade ovarian cancer [30,31].”
BackgroundEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 1×
“. However, the transition from epithelial to mesenchymal cell characteristics encompasses a spectrum of inter- and intracellular changes, not all of which are always seen during EMT”
BackgroundTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855 · cited 1×
“Recent studies have shown that Twist and ZEB1 not only repress E-cadherin expression but also induce the expression of N-cadherin [45,46].”
BackgroundERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2099::aid-cncr8>3.0.co;2-3 · Cited by 2,101
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019 · cited 1×
“A defining feature of EMT is a reduction in E-cadherin levels and a concomitant induction of N-cadherin”
BackgroundMolecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821 · cited 1×
“. Loss of E-cadherin expression is mainly due to an up-regulation of Snail, Slug, Twist, ZEB1 and other transcription factors that repress E-cadherin”
BackgroundRECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS
Carpenter, G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004313 · Cited by 1,281 · cited 1×
“It has been shown that the binding of EGF to EGFR rapidly induces clustering and internalization of the ligandreceptor complexes, ultimately resulting in lysosomal degradation of both EGF and its receptor [21].”
BackgroundShih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Cited by
Targeting EMT in cancer: opportunities for pharmacological intervention
Davis, F. M., Stewart, T. A., Thompson, E. W., & Monteith, G. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.06.006 · Cited by 361
Rizvi, I., Gurkan, U. A., Tasoglu, S., Alagic, N., Celli, J. P., Mensah, L. B., Mai, Z., Demirci, U., & Hasan, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216989110 · Cited by 234
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
Ang, H. L., Mohan, C. D., Shanmugam, M. K., Leong, H. C., Makvandi, P., Rangappa, K. S., Bishayee, A., Kumar, A. P., & Sethi, G. (2023) · Medicinal Research Reviews · doi:10.1002/med.21948 · Cited by 229
Augustine, R., Hasan, A., Dalvi, Y. B., Rehman, S. R. U., Varghese, R., Unni, R. N., Yalcin, H. C., Alfkey, R., Thomas, S., & Al Moustafa, A.-E. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2020.111519 · Cited by 158
“patches compared to other patches which could be due to the activation of several cell motility associated genes and resulting epithelial-mesenchymal transition (EMT) [86].”
BackgroundInfluentialClapéron, A., Mergey, M., Ho-Bouldoires, T. H. N., Vignjevic, D. M., Wendum, D., Chrétien, Y., Merabtene, F., Frazao, A., Paradis, V., Housset, C., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.033 · Cited by 132
Bilyk, O., Coatham, M. L., Jewer, M., & Postovit, L.-M. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00145 · Cited by 145
“Loss of E-cadherin expression paired with ZEB1 expression in a high percentage of epithelial cells is characteristic of EMT and suggests hormonal regulation of the entire process.”
BackgroundInfluentialKao, S.-H., Wang, W.-L., Chen, C.-Y., Chang, Y.-L., Wu, Y.-Y., Wang, Y.-T., Wang, S.-P., Nesvizhskii, A. I., Chen, Y.-J., Hong, T.-M., et al. (2014) · Oncogene · doi:10.1038/onc.2013.279 · Cited by 133
Ha, G., Park, J. S., & Breuer, E.-K. Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.013 · Cited by 130
“EGF induces EMT through the activation of PI3K/Akt, ERK and p38 MAPK signaling pathways [95–97,99–101].”
BackgroundZhou, X., Hu, Y., Dai, L., Wang, Y., Zhou, J., Wang, W., Di, W. J., & Qiu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096718 · Cited by 96
He, X., Chen, Z., Jia, M., & Zhao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070858 · Cited by 97
Wang, Y., Lin, Z., Sun, L., Fan, S., Huang, Z.-P., Zhang, D., Yang, Z., Li, J., & Chen, W. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.770 · Cited by 83
Plasticity of tumor cell invasion: governance by growth factors and cytokines
Odenthal, J., Takes, R. P., & Friedl, P. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw098 · Cited by 86
Luo, B., Xiong, F., Wang, J., Li, J., Zhong, M., Liu, Q., Luo, G., Yang, X., NI, X. Y., Xie, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099922 · Cited by 65
“Furthermore, a recent study demonstrated that EMT is required for EGF-induced large gastric cancer (LGC) and ovarian cancer cell migration and invasion, and that EGF-induced EMT involves activation of the ERK1/2 and PI3K/ AKT pathways with subsequent induction of Snail, Slug, and ZEB1 expression [18].”
BackgroundTACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
Ha, G., Kim, J., & Breuer, E.-K. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070353 · Cited by 65
Epithelial–mesenchymal transition in carcinomas of the female genital tract
Stewart, C. J. R., & McCluggage, W. G. (2012) · Histopathology · doi:10.1111/his.12057 · Cited by 62
“However, recent in-vitro data suggest that EMTmay also contribute towards tumour progression in ovarian endometrioid carcinomas and within the low-grade serous neoplasia pathway.(70,71) It is also true that most studies comprise high-stage tumours classified as ovarian carcinoma using traditional criteria and that les…”
BackgroundCOX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion
Qiu, X. Y., Cheng, J., Chang, H., & Leung, P. C. K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0450 · Cited by 59
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
Li, X., Bi, Z., Liu, S., Gao, S., Cui, Y., Huang, K., Huang, M., Mao, J., Li, L., Gao, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01021 · Cited by 58
Cheng, J., Auersperg, N., & Leung, P. C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042436 · Cited by 63
“Our recent study demonstrated that the ERK1/2 and PI3K/Akt pathways are involved in EGF-induced EMT in SBOT cells [25].”
BackgroundDDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop
Vella, V., Nicolosi, M. L., Cantafio, P., Massimino, M., Lappano, R., Vigneri, P. G., Ciuni, R., Gangemi, P., Morrione, A., Malaguarnera, R., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0310 · Cited by 54
Winitthana, T., Lawanprasert, S., & Pithi Chanvorachote, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110851 · Cited by 49
Qiao, Z., Zhang, Y., Ge, M., Liu, S., Jiang, X., Shang, Z., Liu, H., Cao, C., & Xiao, H. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001502 · Cited by 55
Könnecke, M., Assmann, M., Pries, R., Böscke, R., Bruchhage, K., Ungefroren, H., Klimek, L., & Wollenberg, B. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0409-7 · Cited by 53
“Both TGF-b1 and EGF have been reported to induce EMT (Dennler et al. 2002; Hackett et al. 2009; Miettinen et al. 1994; Nawshad et al. 2005; Thiery et al. 2009) in a variety of benign and malignant epithelial cells (Ahmed et al. 2006; Cheng et al. 2012; Colomiere et al. 2009).”
BackgroundDuan, S., Dong, X., Hai, J., Jiang, J., Wang, W., Yang, J., Zhang, W., & Chen, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.044 · Cited by 51
Zafar, A., Wu, F., Hardy, K., Li, J., Tu, W. J., McCuaig, R., Harris, J. L., Khanna, K. K., Attema, J. L., Gregory, P. A., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01693-13 · Cited by 51
Qiu, X., Klausen, C., Cheng, J.-C., & Leung, P. C. K. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.229 · Cited by 46
Kudlik, G., Takács, T., Radnai, L., Kurilla, A., Szeder, B., Koprivanacz, K., Merő, B. L., Buday, L., & Vas, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218117 · Cited by 48
“EGFR signaling is a known inducer of EMT, causing increased Snail2/Slug and ZEB1 levels and decreased E-cadherin levels [157,158].”
BackgroundChen, T., Xiao, Q., Wang, X., Wang, Z., Hu, J., Zhang, Z., Gong, Z., & Chen, S. (2019) · Journal of International Medical Research · doi:10.1177/0300060519856505 · Cited by 36
“It plays a role upstream of the ERK protein, specifically phosphorylates the ERK protein, and activates the ERK/MAPK signaling pathway, affecting the occurrence and development of tumors.(7,8) MicroRNA, an endogenous singlestranded, non-coding small molecule RNA, which consists of 20 to 24 nucleotides, is involved in…”
BackgroundLiu, B., Han, S., Tang, X., Li, H., & Li, C. (2014) · Oncology Reports · doi:10.3892/or.2014.3119 · Cited by 38
Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma
Zhen, Y., Ye, Y., Yu, X., Mai, C., Zhou, Y. C., Chen, Y., Yang, H., Lyu, X., Song, Y., Wu, Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064976 · Cited by 34
“PI3K/AKT is a classical signal pathway [26], [27] and its activated status induces ell cycle transition of G1/S [28], increases the expression of Snail promoting the EMT [29], [30] and stimulates the secretion of MMP2 and MMP9 [31].”
BackgroundKoch, K., Hartmann, R., Schröter, F., Suwala, A. K., Maciaczyk, D., Krüger, A. C., Willbold, D., Kahlert, U. D., & Maciaczyk, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12337 · Cited by 32
“Therefore, CHKα-mediated EMT induction via activation of EGFR/PI3K/AKT signaling could be a possible explanation for our observations but of course needs further investigations [62, 63].”
ResultKoistinen, V., Härkönen, K., Kärnä, R., Arasu, U. T., Oikari, S., & Rilla, K. J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.12.007 · Cited by 35
Yang, Y., Zhang, J., Zhu, Y., Zhang, Z., Sun, H., & Feng, Y. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000279 · Cited by 30
“The EMT occurs during ovarian cancer progression in response to various stimuli, such as TGF-A and epidermal growth factor.(16,17) In the current study, it was demonstrated that cell morphology, molecular biomarkers, and biological behaviors are consistent with the phenotype of EMT.”
Enhanced EGF receptor-signaling potentiates TGFβ-induced lens epithelial-mesenchymal transition
Shu, D. Y., & Lovicu, F. J. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107693 · Cited by 29
Jung, M. K., Houh, Y. K., Ha, S., Yang, Y., Kim, D., Kim, T. S., Yoon, S. R., Bang, S. I., Cho, B. J., Lee, W. J., et al. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.01.012 · Cited by 24
Ddx4+ Oogonial Stem Cells in Postmenopausal Women’s Ovaries: A Controversial, Undefined Role
Silvestris, E., Cafforio, P., Felici, C., Cormio, G., & D’Oronzo, S. (2019) · Cells · doi:10.3390/cells8070650 · Cited by 24
Zhao, J., Klausen, C., Qiu, X. Y., Cheng, J., Chang, H., & Leung, P. C. K. (2016) · Oncotarget · doi:10.18632/oncotarget.7591 · Cited by 24
Adham, S. A., Al-Harrasi, I., Haddabi, I. A., Rashdi, A. A., Sinawi, S. A., Maniri, A. A., Ba-Omar, T., & Coomber, B. L. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414538821 · Cited by 25
“Most EMT-related studies in ovarian cancer, including EOC, confirmed that both E-cadherin downregulation and N-cadherin up-regulation are responsible for inducing the EMT process (Cheng et al. 2012; Theriault et al. 2011).”
BackgroundHuang, T., Gonzales, C. B., Gu, F., Hsu, Y., Jadhav, R. R., Wang, C., Redding, S. W., Tseng, C.-E., Lee, C.-C., Thompson, I. M., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt112 · Cited by 27
“Activation of these signaling pathways leads to altered activity and expression of downstream genes, including SNAI1, TCF/LEF, TWIST and E-Cadherin, which are known to regulate EMT-mediated cell migration and invasion (47,48).”
BackgroundChen, X., Li, D., Wang, H., Jiao, Y.-Y., Wang, H., Yu, Y., & Zhi, J. (2016) · RSC Advances · doi:10.1039/c6ra04753j · Cited by 22
Xiong, S., Klausen, C., Cheng, J., & Leung, P. C. K. (2016) · Oncotarget · doi:10.18632/oncotarget.9483 · Cited by 22
So, W., Cheng, J., Liu, Y., Xu, C., Zhao, J., Chang, V. T. W., & Leung, P. C. K. (2016) · Tumor Biology · doi:10.1007/s13277-016-4790-y · Cited by 20
Szeder, B., Tárnoki-Zách, J., Lakatos, D., Vas, V., Kudlik, G., Merő, B. L., Koprivanacz, K., Bányai, L., Hámori, L., Róna, G., et al. (2019) · Cells · doi:10.3390/cells8111343 · Cited by 22
“Another group found that EGF upregulates Snail1/2 and ZEB1 expression but does not affect Twist in serous borderline ovarian tumor cells (SBOT) [62].”
BackgroundA cytokine in turmoil: Transforming growth factor beta in cancer
Boye, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111657 · Cited by 23
Zhang, X., Liang, X., Wang, T.-S., Liang, X., Zuo, R.-J., Deng, W., Zhang, Z.-R., Qin, F., Zhao, Z., & Yang, Z. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.011 · Cited by 18
Fan, Q., Cheng, J., Qiu, X. Y., Chang, H., & Leung, P. C. K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.12.097 · Cited by 20
Cheng, J., Chang, H., Xiong, S., So, W., & Leung, P. C. K. (2016) · Oncotarget · doi:10.18632/oncotarget.13162 · Cited by 19
The many microenvironments of ovarian cancer
Micek, H. M., Visetsouk, M. R., Fleszar, A. J., & Kreeger, P. K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_12 · Cited by 14
Spatially Annotated Single Cell Sequencing for Unraveling Intratumor Heterogeneity
Smit, M. M., Feller, K. J., You, L., Storteboom, J., Begce, Y., Beerens, C. E. M. T., & Chien, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.829509 · Cited by 14
MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE‐30
Mahmoudian, R. A., Bahadori, B., Rad, A., Abbaszadegan, M. R., & Forghanifard, M. M. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.746 · Cited by 16
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
“…(especially laminin), dysplasia, loss of cellular polarity of fallopian tube epithelial cells, and release of several soluble factors that regulate ROS-induced stress, anoikis, invasion and cell growth (Cheng et al., 2012; Alsina-Sanchis et al., 2016; Huang et al., 2016; Micek et al., 2020).”
BackgroundChen, R., Tao, X., Wu, B., Li, J., Wang, J., Gu, W., & Lu, X. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14210 · Cited by 12
“For advanced stage ovarian cancer, it is even lower to 5–10%.(7) However, there were no large series addressing the prognostic significance of IECA in MBOTs.”
BackgroundLi, C., Wang, Y., Lin, Z., Yang, L., Gao, S., Liu, T., Zou, B., Pan, Z., Song, Z., & Liu, G. (2017) · PubMed · Cited by 15
Liu, R., Zheng, J., Li, C., Pang, Y., Zheng, Q., Xu, X., & Liu, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3555-3 · Cited by 10
Kim, G. T., Lee, S. H., & Kim, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2546 · Cited by 10
“Previous studies have found that breast cancer cells and other carcinoma induce EMT when cells are exposed to EGF (30-32); thus, modulating EGF is an obvious strategy to regulate breast cancer progression and abnormal metastasis.”
BackgroundFascin-1 expression as stratification marker in borderline epithelial tumours of the ovary
El‐Balat, A., Arsenić, R., Sänger, N., Karn, T., Becker, S., Holtrich, U., & Engels, K. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203224 · Cited by 9
Carbone, L., Incognito, G. G., Incognito, D., Nibid, L., Caruso, G., Berretta, M., Taffon, C., Palumbo, M. A., Perrone, G., Roviello, F., et al. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03837-2 · Cited by 11
“EMT is essential for the transition from serous borderline OC to low-grade serous type, resulting in reduced levels of E-cadherin and increased expression of TFs [34].”
TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary
El‐Balat, A., Schmeil, I., Karn, T., Becker, S., Sänger, N., Holtrich, U., & Arsenić, R. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0240-4 · Cited by 7
Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
Ha, G., Kim, J., & Breuer, E.-K. Y. (2013) · PLoS ONE · doi:10.1371/annotation/23c9bde1-5ced-4eb9-8a73-c53f3f2913d4 · Cited by 4
Epidermal Growth Factor Is Increased in Conjunctival Malignant Melanoma
Kakkassery, V., Wirtz, C., Schargus, M., Grisanti, S., Tura, A., Ranjbar, M., Dick, H. B., Reinehr, S., & Joachim, S. C. (2021) · In Vivo · doi:10.21873/invivo.12666 · Cited by 3
The development and progression of low-grade serous ovarian carcinoma
Wong, K., & Gershenson, D. M. (2024) · Academia oncology. · doi:10.20935/acadonco7338 · Cited by 2
Samudio‐Ruiz, S. L. (2014) · Medicinal Chemistry · doi:10.4172/2161-0444.s1-005 · Cited by 1
“In the current studies, we found no changes in the levels of E-cadherin or E-cadherin transcription regulators (Slug, Snail, Twist) after long term EGF, although other markers of EMT such as vimentin and N-cadherin were upregulated suggesting that mechanisms and outcomes to short term versus persistent EGFR activation…”
BackgroundResultInfluentialExpression of E-cadherin in Colorectal Cancer and Its Association with Morphological Features
Hydru, S. P., & Das, N. M. (2022) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2022/31 · Cited by 1
Canchaya, G. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-05012017-095632
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416570-0.00043-3
EFFECTS OF ZINC ION ON EPITHELIAL TO MESENCHYMAL TRANSITION AND CANCER STEMNESS OF LUNG CANCER CELLS
Ninsontia, C. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1792
Szeder, B. (2023) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2022.152 · Cited by 1
Metadata
- Authors
- Cheng, J.-C., Auersperg, N., & Leung, P. C. K.
- Affiliations
- University of British Columbia (CA)
- University of Central Florida (US)
- Corresponding author
- Leung, Peter C. K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-30
- Volume
- 7
- Issue
- 3
- Pages
- e34071
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3316602
- OpenAlex
- W2013958001
- Cited by
- 66
- References
- 46
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 7 · 2018: 2 · 2017: 4 · 2016: 10 · 2015: 3 · 2014: 13 · 2013: 12 · 2012: 2
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- epidermal growth factor, epithelial-mesenchymal transition, serous borderline ovarian tumor, low-grade serous carcinoma, cell invasion, cell migration, EGF receptor, E-cadherin, N-cadherin, snails, Slug, ZEB1, ERK signaling, PI3K/Akt signaling, MEK1 inhibition, PD98059
- MeSH terms
- Cell Movement, Chromones, Epidermal Growth Factor, Female, Flavonoids, Humans, Morpholines, Neoplasm Invasiveness, Ovarian Neoplasms, Cadherins, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Cystadenocarcinoma, Serous, Gene Expression Profiling, Cell Line, Tumor, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.